journal
https://read.qxmd.com/read/37737921/correction-to-mir-101-3p-inhibits-emt-to-attenuate-proliferation-and-metastasis-in-glioblastoma-by-targeting-trim44
#1
Ling Li, Mei-Ying Shao, Shu-Cheng Zou, Zhe-Feng Xiao, Zhu-Chu Chen
No abstract text is available yet for this article.
September 22, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37733174/reirradiation-versus-systemic-therapy-versus-combination-therapy-for-recurrent-high-grade-glioma-a-systematic-review-and-meta-analysis-of-survival-and-toxicity
#2
REVIEW
Ravi Marwah, Daniel Xing, Timothy Squire, Yu Yang Soon, Hui K Gan, Sweet Ping Ng
PURPOSE: This review compares reirradiation (reRT), systemic therapy and combination therapy (reRT & systemic therapy) with regards to overall survival (OS), progression-free survival (PFS), adverse effects (AEs) and quality of life (QoL) in patients with recurrent high-grade glioma (rHGG). METHODS: A search was performed on PubMed, Scopus, Embase and CENTRAL. Studies reporting OS, PFS, AEs and/or QoL and encompassing the following groups were included; reirradiation vs systemic therapy, combination therapy vs systemic therapy, combination therapy vs reRT, and bevacizumab-based combination therapy vs reRT with/without non-bevacizumab-based systemic therapy...
September 21, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37728779/undetected-pseudoprogressions-in-the-ceteg-noa-09-trial-hints-from-postprogression-survival-and-mri-analyses
#3
JOURNAL ARTICLE
Thomas Zeyen, Daniel Paech, Johannes Weller, Niklas Schäfer, Theophilos Tzaridis, Cathrina Duffy, Louisa Nitsch, Matthias Schneider, Anna-Laura Potthoff, Joachim Peter Steinbach, Peter Hau, Uwe Schlegel, Clemens Seidel, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Pia Susan Zeiner, Ghazaleh Tabatabai, Norbert Galldiks, Walter Stummer, Elke Hattingen, Martin Glas, Alexander Radbruch, Ulrich Herrlinger, Christina Schaub
PURPOSE: In the randomized CeTeG/NOA-09 trial, lomustine/temozolomide (CCNU/TMZ) was superior to TMZ therapy regarding overall survival (OS) in MGMT promotor-methylated glioblastoma. Progression-free survival (PFS) and pseudoprogression rates (about 10%) were similar in both arms. Further evaluating this discrepancy, we analyzed patterns of postprogression survival (PPS) and MRI features at first progression according to modified RANO criteria (mRANO). METHODS: We classified the patients of the CeTeG/NOA-09 trial according to long vs...
September 20, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37721663/comments-neurosurgery-and-radiation-oncology-advances-have-improved-visual-outcomes-for-skull-base-meningioma-patients
#4
LETTER
Jason P Sheehan, Daniel M Trifiletti
No abstract text is available yet for this article.
September 18, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37721662/improved-survival-and-intracranial-tumor-control-of-egfr-mutated-nsclc-patients-with-newly-developed-brain-metastases-following-stereotactic-radiosurgery-and-egfr-tki-a-large-retrospective-cohort-study-and-meta-analyses
#5
JOURNAL ARTICLE
Ai Seon Kuan, Chi-Lu Chiang, Hsiu-Mei Wu, Huai-Che Yang, Ching-Jen Chen, Chung-Jung Lin, Wan-Yuo Guo, David Hung-Chi Pan, Wen-Yuh Chung, Cheng-Chia Lee
PURPOSE: To examine the differential effects of SRS and TKI on EGFR-mutated NSCLC patients with brain metastases (BMs) and outcomes following continuation of the same TKI agent in case of new BMs. METHODS: This study included 608 NSCLC patients (2,274 BMs) while meta-analyses included 1,651 NSCLC patients (> 3,944 BMs). Overall survival (OS) and intracranial progression free survival (iPFS) were estimated using Kaplan-Meier methods. Hazard ratios (95% CI) of prognostic factors were estimated using Cox regression models...
September 18, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37710025/intratumoral-thrombosis-as-a-histological-biomarker-for-predicting-epidermal-growth-factor-receptor-alteration-and-poor-prognosis-in-patients-with-glioblastomas
#6
JOURNAL ARTICLE
Takuya Furuta, Tetsuya Negoto, Hiroaki Miyoshi, Mayuko Moritsubo, Hideo Nakamura, Motohiro Morioka, Jun Akiba, Koichi Ohshima, Yasuo Sugita
PURPOSE: Intratumoral thrombosis is a specific finding in glioblastomas and considered the origin of palisading necrosis. Its distribution and contribution to the glioblastoma pathophysiology and systemic thrombosis are obscure, although deep vein thrombosis is a common complication in glioblastoma cases. METHODS: Clinicopathological and genetic analyses were performed on 97 glioblastoma tissue specimens to elucidate the role of thrombotic events and associated molecular abnormalities...
September 14, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37707754/somatostatin-receptor-subtype-expression-and-radiomics-from-dwi-mri-represent-suv-of-68ga-ga-dotatoc-pet-in-patients-with-meningioma
#7
JOURNAL ARTICLE
Sarah Iglseder, Anna Iglseder, Vincent Beliveau, Johanna Heugenhauser, Elke R Gizewski, Johannes Kerschbaumer, Guenther Stockhammer, Christian Uprimny, Irene Virgolini, Jozsef Dudas, Meinhard Nevinny-Stickel, Martha Nowosielski, Christoph Scherfler
OBJECTIVE: This retrospective study aimed to analyse the correlation between somatostatin receptor subtypes (SSTR 1-5) and maximum standardized uptake value (SUVmax ) in meningioma patients using Gallium-68 DOTA-D-Phe1-Tyr3-octreotide Positron Emission Tomography ([68Ga]Ga-DOTATOC PET). Secondly, we developed a radiomic model based on apparent diffusion coefficient (ADC) maps derived from diffusion weighted magnetic resonance images (DWI MRI) to reproduce SUVmax . METHOD: The study included 51 patients who underwent MRI and [68Ga]Ga-DOTATOC PET before meningioma surgery...
September 14, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37707753/seizure-outcomes-after-resection-of-primary-brain-tumors-in-pediatric-patients-a-systematic-review-and-meta-analysis
#8
REVIEW
Kalman A Katlowitz, Prazwal Athukuri, Himanshu Sharma, Huy Dang, Astitva Soni, A Basit Khan, Fatema Malbari, Nisha Gadgil, Howard L Weiner
PURPOSE: Primary brain neoplasms are the most common solid tumors in pediatric patients and seizures are a common presenting symptom. Surgical intervention improves oncologic outcomes and seizure burden. A better understanding of factors that influence seizure outcomes in the surgical management of primary brain tumors of childhood can guide treatment approach thereby improving patient quality of life. METHODS: We performed a systematic analysis using articles queried from PubMed, EMBASE, and Cochrane published from January 1990 to August 2022 to determine predictors of seizure outcomes in pediatric patients undergoing resection of primary brain tumors...
September 14, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37707752/relationship-between-apparent-diffusion-coefficient-and-survival-as-a-function-of-distance-from-gross-tumor-volume-on-radiation-planning-mri-in-newly-diagnosed-glioblastoma
#9
JOURNAL ARTICLE
Pejman Jabehdar Maralani, James Stewart, Shivaprakash Hiremath, Liam Lawrence, Rachel Chan, Angus Lau, Hanbo Chen, Aimee Chan, Liang K Zeng, Chia-Lin Tseng, Sten Myrehaug, Hany Soliman, Jay Detsky, Chinthaka Heyn, MaryJane Lim Fat, Nir Lipsman, Arjun Sahgal
PURPOSE: To investigate the changes in apparent diffusion coefficient (ADC) within incrementally-increased margins beyond the gross tumor volume (GTV) on post-operative radiation planning MRI and their prognostic utility in glioblastoma. METHODS: Radiation planning MRIs of adult patients with newly diagnosed glioblastoma from 2017 to 2020 were assessed. The ADC values were normalized to contralateral normal white matter (nADC). Using 1 mm isotropic incremental margin increases from the GTV, the nADC values were calculated at each increment...
September 14, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37702975/long-term-clinical-outcomes-of-stereotactic-radiotherapy-for-bilateral-vestibular-schwannomas-in-neurofibromatosis-type-2-patients
#10
JOURNAL ARTICLE
Putipun Puataweepong, Mantana Dhanacha, Rawee Ruangkanchanasetr, Keeratikarn Boonyawan, Ake Hansasuta, Kriangsak Saetia, Pornpan Yongvithisatid
PURPOSE: The evidence for treating patients with neurofibromatosis 2-related vestibular schwannoma (VS-NF2) using hypofractionated stereotactic radiation therapy (HSRT) is limited. This study aimed to investigate clinical outcomes in patients with VS-NF2 treated with Robotic HSRT. METHODS: We retrospectively analyzed 25 NF2 patients with 48 VSs who were treated using Robotic HSRT at Ramathibodi Hospital from January 2009 to January 2020. RESULTS: Median follow-up was 98 months (range, 24-155 months)...
September 13, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37698707/the-state-of-art-of-awake-craniotomy-in-latin-american-countries-a-scoping-review
#11
REVIEW
Luisa F Figueredo, William J Shelton, Uriel Tagle-Vega, Emiliano Sanchez, Leonardo de Macedo Filho, Andres F Salazar, Renata Murguiondo-Pérez, Santiago Fuentes, Lina Marenco-Hillembrand, Paola Suarez-Meade, Edgar Ordoñez-Rubiano, Diego Gomez Amarillo, Lucas Alverne F Albuquerque, Robson Luis Oliveira de Amorim, Carlos M Vasquez, Matias Baldoncini, Juan Armando Mejia, Claudia Niño, Juan Fernando Ramon, Fernando Hakim, Diego Mendez-Rosito, Jorge Navarro-Bonnet, Alfredo Quiñones-Hinojosa, Joao Paulo Almeida
BACKGROUND AND OBJECTIVE: Awake craniotomy (AC) is a valuable technique for surgical interventions in eloquent areas, but its adoption in low- and middle-income countries faces challenges like limited infrastructure, trained personnel shortage, and inadequate funding. This scoping review explores AC techniques in Latin American countries, focusing on patient characteristics, tumor location, symptomatology, and outcomes. METHODS: A scoping review followed PRISMA guidelines, searching five databases in English, Spanish, and Portuguese...
September 12, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37697210/the-role-of-cytoreductive-surgery-in-multifocal-multicentric-glioblastomas
#12
JOURNAL ARTICLE
Diyan Dimov, Daniel Brainman, Björn Berger, Roland Coras, Alexander Grote, Matthias Simon
PURPOSE: Multifocal/multicentric glioblastomas (mGBM) account for up to 20% of all newly diagnosed glioblastomas. The present study investigates the impact of cytoreductive surgery on survival and functional outcomes in patients with mGBM. METHODS: We retrospectively reviewed clinical and imaging data of 71 patients with newly diagnosed primary (IDH1 wildtype) mGBM who underwent operative treatment in 2015-2020 at the authors' institution. Multicentric/multifocal growth was defined by the presence of ≥ 2 contrast enhancing lesions ≥ 1 cm apart from each other...
September 12, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37695488/the-prognostic-power-of-11-c-methionine-pet-in-idh-wildtype-diffuse-gliomas-with-lower-grade-histological-features-venturing-beyond-who-classification
#13
JOURNAL ARTICLE
Gaia Ninatti, Cristiano Pini, Beatrice Claudia Bono, Fabrizia Gelardi, Lidija Antunovic, Bethania Fernandes, Martina Sollini, Claudio Landoni, Arturo Chiti, Federico Pessina
PURPOSE: IDH-wildtype (IDH-wt) diffuse gliomas with histological features of lower-grade gliomas (LGGs) are rare and heterogeneous primary brain tumours. [11 C]Methionine (MET) positron emission tomography (PET) is commonly used to evaluate glial neoplasms at diagnosis. The present study aimed to assess the prognostic value of MET PET in newly diagnosed, treatment naïve IDH-wt gliomas with histological features of LGGs. METHODS: Patients with a histological diagnosis of IDH-wt LGG who underwent preoperative (< 100 days) MET PET/CT and surgery were retrospectively included...
September 11, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37691032/egfr-mutated-non-small-lung-cancer-brain-metastases-and-radiosurgery-outcomes-with-a-focus-on-leptomeningeal-disease
#14
JOURNAL ARTICLE
Juan Diego Alzate, Reed Mullen, Elad Mashiach, Kenneth Bernstein, Fernando De Nigris Vasconcellos, Lauren Rotmann, Assaf Berger, Tanxia Qu, Joshua S Silverman, John G Golfinos, Bernadine R Donahue, Douglas Kondziolka
PURPOSE: Patients with EGFR-mutated NSCLC represent a unique subset of lung cancer patients with distinct clinical and molecular characteristics. Previous studies have shown a higher incidence of brain metastases (BM) in this subgroup of patients, and neurologic death has been reported to be as high as 40% and correlates with leptomeningeal disease (LMD). METHODS: Between 2012 and 2021, a retrospective review of our prospective registry identified 606 patients with BM from NSCLC, with 170 patients having an EGFR mutation...
September 10, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37689596/dynamic-contrast-enhanced-mri-radiomics-model-predicts-epidermal-growth-factor-receptor-amplification-in-glioblastoma-idh-wildtype
#15
JOURNAL ARTICLE
Beomseok Sohn, Kisung Park, Sung Soo Ahn, Yae Won Park, Seung Hong Choi, Seok-Gu Kang, Se Hoon Kim, Jong Hee Chang, Seung-Koo Lee
PURPOSE: To develop and validate a dynamic contrast-enhanced (DCE) MRI-based radiomics model to predict epidermal growth factor receptor (EGFR) amplification in patients with glioblastoma, isocitrate dehydrogenase (IDH) wildtype. METHODS: Patients with pathologically confirmed glioblastoma, IDH wildtype, from January 2015 to December 2020, with an EGFR amplification status, were included. Patients who did not undergo DCE or conventional brain MRI were excluded. Patients were categorized into training and test sets by a ratio of 7:3...
September 10, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37668945/decision-system-for-extent-of-resection-in-who-grade-3-gliomas-a-chinese-glioma-genome-atlas-database-analysis
#16
JOURNAL ARTICLE
Ziming Hou, Jie Hu, Xing Liu, Zeya Yan, Kenan Zhang, Shengyu Fang, Tao Jiang, Yinyan Wang
BACKGROUND: Extensive surgical resection has been found to be associated with longer survival in patients with gliomas, but the interactive prognostic value of molecular pathology of the surgical resection is unclear. This study evaluated the impact of molecular pathology and clinical characteristics on the surgical benefit in WHO grade 3 IDH-mutant gliomas. METHODS: Clinical and pathological information of 246 patients with WHO grade 3 IDH-mutant gliomas were collected from the Chinese Glioma Genome Atlas database (2006-2020)...
September 5, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37668944/intracranial-intraoperative-radiotherapy-iort-evaluation-of-electrocorticography-and-peri-operative-seizure-risk
#17
JOURNAL ARTICLE
Christopher P Cifarelli, John A Vargo, Ugur Sener, Daniel T Cifarelli, David Scoville, Aman Dabir
BACKGROUND: Intra-operative radiotherapy (IORT) for brain metastases (BMs) and primary brain tumors has emerged as an adjuvant radiation modality that allows for consolidation of care into a single anesthetic episode with surgical resection. Yet, there is a paucity of data regarding the impact that IORT may have on peri-operative and long-term seizure risk. METHODS: A retrospective analysis of patients receiving IORT during tumor resection was performed via registry including data regarding peri-operative anti-seizure medications and anesthetic agents...
September 5, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37668943/neuropsychological-impairment-in-primary-malignant-brain-tumor-patients-with-awake-craniotomy-a-hospital-based-registration-study
#18
JOURNAL ARTICLE
Yah-Yuan Wu, Ko-Ting Chen, Yi-Chuan Chu, Chun-Chang Yeh, Wei-Chia Chen, Pin-Yuan Chen, Wei-Han Chang, Kuo-Chen Wei, Yi-Chun Chen
PURPOSE: Neuroplasticity is an ability to maintain neural circuit function when facing damages. It is one of the reasons that making brain tumors notorious. Therefore, we evaluated the characteristics of patients with primary brain tumors, compared neuropsychological deficits between patients who had awake craniotomy with left- or right-sided tumors, and analyzed the association between white matter tracts and neuropsychological deficits in patients with right-sided tumors. METHODS: Using the registration dataset of Chang Gung Memory Hospital between 2014 and 2020, this study included a total of 698 adult patients who received craniotomy for primary brain tumors (538 of conventional craniotomy; 160 of awake craniotomy)...
September 5, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37668942/letter-to-the-editor-outcome-of-glioblastoma-patients-after-intensive-care-unit-admission-with-invasive-mechanical-ventilation-a-multicenter-analysis
#19
LETTER
Abigail N Murtha, Peter G Zaki, Matthew J Shepard
No abstract text is available yet for this article.
September 5, 2023: Journal of Neuro-oncology
https://read.qxmd.com/read/37668941/predicting-survival-in-glioblastoma-with-multimodal-neuroimaging-and-machine-learning
#20
JOURNAL ARTICLE
Patrick H Luckett, Michael Olufawo, Bidhan Lamichhane, Ki Yun Park, Donna Dierker, Gabriel Trevino Verastegui, Peter Yang, Albert H Kim, Milan G Chheda, Abraham Z Snyder, Joshua S Shimony, Eric C Leuthardt
PURPOSE: Glioblastoma (GBM) is the most common and aggressive malignant glioma, with an overall median survival of less than two years. The ability to predict survival before treatment in GBM patients would lead to improved disease management, clinical trial enrollment, and patient care. METHODS: GBM patients (N = 133, mean age 60.8 years, median survival 14.1 months, 57.9% male) were retrospectively recruited from the neurosurgery brain tumor service at Washington University Medical Center...
September 5, 2023: Journal of Neuro-oncology
journal
journal
28661
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.